Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Vitamin D levels and early mortality among incident hemodialysis patients.

Wolf M, Shah A, Gutierrez O, Ankers E, Monroy M, Tamez H, Steele D, Chang Y, Camargo CA Jr, Tonelli M, Thadhani R.

Kidney Int. 2007 Oct;72(8):1004-13. Epub 2007 Aug 8.

2.

Vitamin D as a novel nontraditional risk factor for mortality in hemodialysis patients.

Pecovnik-Balon B, Jakopin E, Bevc S, Knehtl M, Gorenjak M.

Ther Apher Dial. 2009 Aug;13(4):268-72. doi: 10.1111/j.1744-9987.2009.00722.x.

PMID:
19695057
4.

Vitamin D deficiency and anemia in early chronic kidney disease.

Patel NM, Gutiérrez OM, Andress DL, Coyne DW, Levin A, Wolf M.

Kidney Int. 2010 Apr;77(8):715-20. doi: 10.1038/ki.2009.551. Epub 2010 Feb 3.

5.

Vitamin D status and clinical outcomes in incident dialysis patients: results from the NECOSAD study.

Drechsler C, Verduijn M, Pilz S, Dekker FW, Krediet RT, Ritz E, Wanner C, Boeschoten EW, Brandenburg V; NECOSAD Study Group.

Nephrol Dial Transplant. 2011 Mar;26(3):1024-32. doi: 10.1093/ndt/gfq606. Epub 2010 Oct 14.

PMID:
20947538
6.

Economic analysis of cinacalcet in combination with low-dose vitamin D versus flexible-dose vitamin D in treating secondary hyperparathyroidism in hemodialysis patients.

Shireman TI, Almehmi A, Wetmore JB, Lu J, Pregenzer M, Quarles LD.

Am J Kidney Dis. 2010 Dec;56(6):1108-16. doi: 10.1053/j.ajkd.2010.07.012. Epub 2010 Oct 15.

PMID:
20951487
7.

Vitamin D deficiency, inflammation, and albuminuria in chronic kidney disease: complex interactions.

Isakova T, Gutiérrez OM, Patel NM, Andress DL, Wolf M, Levin A.

J Ren Nutr. 2011 Jul;21(4):295-302. doi: 10.1053/j.jrn.2010.07.002. Epub 2010 Sep 3.

PMID:
20817560
8.

Vitamin D receptor agonist supplementation and suppression of inflammation may have advantage for all-cause mortality in hemodialysis patients.

Ogawa T, Kyono A, Sato M, Sugimoto H, Otsuka K, Nitta K.

Clin Exp Nephrol. 2012 Oct;16(5):779-85. doi: 10.1007/s10157-012-0626-2. Epub 2012 Mar 29.

PMID:
22457088
9.

Bioavailable vitamin D is more tightly linked to mineral metabolism than total vitamin D in incident hemodialysis patients.

Bhan I, Powe CE, Berg AH, Ankers E, Wenger JB, Karumanchi SA, Thadhani RI.

Kidney Int. 2012 Jul;82(1):84-9. doi: 10.1038/ki.2012.19. Epub 2012 Mar 7.

10.

Distinct impact of vitamin D insufficiency on calcitriol levels in chronic renal failure and renal transplant patients: a role for FGF23.

Mazzaferro S, Pasquali M, Pugliese F, Citterio F, Gargiulo A, Rotondi S, Tartaglione L, Conte C, Pirrò G, Taggi F.

J Nephrol. 2012 Nov-Dec;25(6):1108-18. doi: 10.5301/jn.5000102.

PMID:
22383345
11.

Abnormal mineral metabolism and mortality in hemodialysis patients with secondary hyperparathyroidism: evidence from marginal structural models used to adjust for time-dependent confounding.

Fukagawa M, Kido R, Komaba H, Onishi Y, Yamaguchi T, Hasegawa T, Kurita N, Fukuma S, Akizawa T, Fukuhara S.

Am J Kidney Dis. 2014 Jun;63(6):979-87. doi: 10.1053/j.ajkd.2013.08.011. Epub 2013 Oct 8.

PMID:
24119541
12.

Vitamin D affects survival independently of vascular calcification in chronic kidney disease.

Barreto DV, Barreto FC, Liabeuf S, Temmar M, Boitte F, Choukroun G, Fournier A, Massy ZA.

Clin J Am Soc Nephrol. 2009 Jun;4(6):1128-35. doi: 10.2215/CJN.00260109. Epub 2009 May 14.

13.

Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters.

Matias PJ, Jorge C, Ferreira C, Borges M, Aires I, Amaral T, Gil C, Cortez J, Ferreira A.

Clin J Am Soc Nephrol. 2010 May;5(5):905-11. doi: 10.2215/CJN.06510909. Epub 2010 Mar 4.

14.

Activated injectable vitamin D and hemodialysis survival: a historical cohort study.

Teng M, Wolf M, Ofsthun MN, Lazarus JM, Hernán MA, Camargo CA Jr, Thadhani R.

J Am Soc Nephrol. 2005 Apr;16(4):1115-25. Epub 2005 Feb 23.

15.

Impact of race on hyperparathyroidism, mineral disarrays, administered vitamin D mimetic, and survival in hemodialysis patients.

Kalantar-Zadeh K, Miller JE, Kovesdy CP, Mehrotra R, Lukowsky LR, Streja E, Ricks J, Jing J, Nissenson AR, Greenland S, Norris KC.

J Bone Miner Res. 2010 Dec;25(12):2724-34. doi: 10.1002/jbmr.177. Epub 2010 Jul 7. Erratum in: J Bone Miner Res. 2011 Feb;26(2):439.

16.

Clinical significance of FGF-23 measurement in dialysis patients.

Jongbloed F, Galassi A, Cozzolino M, Zietse R, Chiarelli G, Cusi D, Brancaccio D, Gallieni M.

Clin Nephrol. 2011 Sep;76(3):201-9.

PMID:
21888857
17.

Vitamin D status and mortality in chronic kidney disease.

Pilz S, Tomaschitz A, Friedl C, Amrein K, Drechsler C, Ritz E, Boehm BO, Grammer TB, März W.

Nephrol Dial Transplant. 2011 Nov;26(11):3603-9. doi: 10.1093/ndt/gfr076. Epub 2011 Mar 4.

PMID:
21378153
18.

Paricalcitol as compared with calcitriol in patients undergoing hemodialysis.

Drüeke TB, McCarron DA.

N Engl J Med. 2003 Jul 31;349(5):496-9. No abstract available.

PMID:
12890849
19.

Vitamin D deficiency and associated factors in hemodialysis patients.

Jean G, Charra B, Chazot C.

J Ren Nutr. 2008 Sep;18(5):395-9. doi: 10.1053/j.jrn.2008.04.003.

PMID:
18721733
20.

Mineral metabolism disturbances in patients with chronic kidney disease.

Kestenbaum B, Belozeroff V.

Eur J Clin Invest. 2007 Aug;37(8):607-22. Review.

PMID:
17635571

Supplemental Content

Support Center